Related Experiment Video
Updated: Aug 10, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Retinoids, retinoic acid receptors, and breast cancer
Jisun Paik1, William S Blaner, Karen M Sommer
1Department of Medicine, Institute of Human Nutrition, Columbia University, New York, New York, USA.
Abstract:
Retinoids comprise both naturally and synthetically occurring compounds that have been proven to be differentiation agents for a variety of neoplasias, including breast cancer and promyelocytic leukemia in animal models and humans. They offer a unique panoply of therapeutics for the prevention or treatment of breast cancer. Nonetheless, considerable controversy remains as to the efficacy and potential toxic side-effects and as to which group of patients may most benefit. In this article, we review evidence of retinoid efficacy in breast cancer in humans and in animal models and provide possible mechanisms of retinoid action in breast cancer treatment, focusing on the roles of the different retinoic acid receptors and the metabolic pathways necessary for gene activation and cellular homeostasis.
Insights
Retinoids show promise in treating breast cancer by promoting cell differentiation. Further research is needed to clarify their efficacy, side effects, and optimal patient selection for retinoid therapy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Retinoids are compounds with proven differentiation capabilities.
- They are investigated for breast cancer prevention and treatment.
- Controversy exists regarding their efficacy, toxicity, and patient suitability.
Purpose of the Study:
- To review evidence on retinoid efficacy in human and animal breast cancer models.
- To explore potential mechanisms of retinoid action in breast cancer.
- To focus on retinoic acid receptors and metabolic pathways in gene activation.
Main Methods:
- Review of existing scientific literature on retinoids and breast cancer.
- Analysis of preclinical (animal models) and clinical (human) data.
- Examination of molecular mechanisms involving retinoic acid receptors.
Main Results:
- Evidence suggests retinoids can act as differentiation agents in various neoplasias.
- Retinoids offer potential therapeutic strategies for breast cancer.
- Mechanisms involve retinoic acid receptors and metabolic pathways for gene regulation.
Conclusions:
- Retinoids present a unique therapeutic avenue for breast cancer.
- Further investigation is required to address efficacy and toxicity concerns.
- Understanding patient-specific benefits and optimal use is crucial.
More Related Videos
05:03Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
08:18Methodology for Studying Interactions of Vitamin A Membrane Receptors and Opsin Protein with their Ligands in Generating the Retinylidene Protein
Published on: October 4, 2024
Related Concept Videos
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Acne Infection